Skip to main content
SpringerLink
Log in

Management of spasticity, pain, and paroxysmal phenomena in multiple sclerosis

  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

Multiple sclerosis (MS) is a disease with tremendous variability and innumerable symptoms. Among the more common symptoms is spasticity. Despite a lack of full knowledge of the physiology causing this phenomenon, successful treatments have been developed. Many of these have had a recent introduction. Pain and paroxysmal phenomena are surprisingly common in MS, but have not had the recognition their frequency deserves. It is not unusual to hear that they are rare in MS, but surprisingly they are all too common. Their management is changing as newer treatments are developed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Young RR: Treatment of spastic paresis. N Engl J Med 1989, 320:1553–1555.

    Article  PubMed  CAS  Google Scholar 

  2. Young RR: Spastic paresis. In Multiple Sclerosis Diagnosis, Medical Management, and Rehabilitation. Edited by Burks JS, Johnson KP. New York: Demos Medical Publishing; 2000:299–306. This is an overview of spasticity in multiple sclerosis, with a review of physiology and management.

    Google Scholar 

  3. Young RR: Spasticity: a review. Neurology 1994, 44(suppl 9):S12–20.

    PubMed  CAS  Google Scholar 

  4. Filloux FM: Neuropathophysiology of movement disorders in cerebral palsy. J Child Neurol 1996, 11(suppl 1):S5-S12.

    PubMed  Google Scholar 

  5. Olson Jr WL, Abrams BM: Management of spasticity in neurological disorders. Progress in Neurology 1999, 1:1–19. This is a very thorough review of all forms of spasticity with many references. It involves physiology and neurochemistry.

    Google Scholar 

  6. Brown P: Pathophysiology of spasticity. J Neurol Neurosurg Psychiatry 1994, 57:773–777.

    PubMed  CAS  Google Scholar 

  7. Paty DW, Ebers GC: Clinical Features in Multiple Sclerosis. Philadelphia: FA Davis;

  8. Ashworth B: Preliminary trial of corisprodol in multiple sclerosis. Practitioner 1964, 192:540–542.

    PubMed  CAS  Google Scholar 

  9. Vajd T, Vodovnik L: Pendulum testing of spasticity. J Biomed Eng 1984, 6:9–16.

    Article  Google Scholar 

  10. Bianchi L, Monaldi F, Paolucci S, et al.: Quantitative analysis of the pendulum test: application to multiple sclerosis patients treated with botulinum toxin. Funct Neurol 1999, 14:79–92.

    PubMed  CAS  Google Scholar 

  11. Gracies JM, Nance P, Eolvic E, et al.: Traditional pharmacological treatments for spasticity. Part II: General and regional treatments. Muscle Nerve Suppl 1997, 6:S92–120.

    Article  PubMed  CAS  Google Scholar 

  12. Cendrowski W, Sobazyk M, Olson WL: Clonazapam, baclofen and placebo in the treatment of spasticity. Eur Neurol 1977, 16:275–262.

    Google Scholar 

  13. Penn RD, Savoy SM, Corcos E, et al.: Intrathecal baclofen for severe spinal spasticity. N Engl J Med 1989, 320:1517–1521.

    Article  PubMed  CAS  Google Scholar 

  14. Bes A, Eyssette M, Pierrot-Deseilligny E, et al.: A multi-centre, double blind trial of tizanidine, a new antispastic agent in spasticity associated with hemiplegia. Curr Med Res Opin 1988, 10:709–718.

    PubMed  CAS  Google Scholar 

  15. Groves L, Shellenberger MK, Davis CS: Tizanidine treatment of spasticity: a meta-analysis of controlled double-blind, comparative studies with baclofen and diazepam. Adv Ther 1998, 15:241–251.

    PubMed  CAS  Google Scholar 

  16. Mueller ME, Gruenthal M, Olson WL, Olson WH: Gabapentin for relief of upper motor neuron symptoms in multiple sclerosis. Arch Phys Med Rehabil 1997, 78:521–524.

    Article  PubMed  CAS  Google Scholar 

  17. Dunevsky A, Perel AB: Gabapentin for relief of spasticity associated with multiple sclerosis. Am J Phys Med Rehabil 1998, 77:451–454.

    Article  PubMed  CAS  Google Scholar 

  18. Gruenthal M, Mueller M, Olson WL, et al.: Gabapentin for the treatment of spasticity in patients with spinal cord injury. Spinal Cord 1997, 35:686–689.

    Article  PubMed  CAS  Google Scholar 

  19. Cutter NC, Scott DD, Johnson JC, Whiteneck G: Gabapentin effect of spasticity in multiple sclerosis: a placebo-controlled, randomized trial. Arch Phys Med Rehabil 2000, 81:164–169.

    PubMed  CAS  Google Scholar 

  20. Hyman N, Barnes M, Bhakta B, et al.: Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomized, double blind, placebo controlled, dose ranging study; J Neurol Neurosurg Psychiatry 2000, 68:707–712.

    Article  PubMed  CAS  Google Scholar 

  21. Snow BJ, Tsui JK, Bhatt MH, et al.: Treatment of spasticity with botulinum toxin: a double blind study. Ann Neurol 1990, 28:512–515.

    Article  PubMed  CAS  Google Scholar 

  22. Pertwee RG: Cannabis and cannabinoids: pharmacology and rationale for clinical use. Forsch Komplementarmed 1999, 6(suppl 3):12–15.

    Article  PubMed  Google Scholar 

  23. Pertwee RG: Pharmacology of cannabinoid receptor ligands. Curr Med Chem 1999, 6:635–664.

    PubMed  CAS  Google Scholar 

  24. Clifford DB, Trotter JL: Pain in multiple sclerosis. Arch Neurol 1984, 41:1270–1272.

    PubMed  CAS  Google Scholar 

  25. Indaco A, Iachetta C, Socci L, Carrieri PB: Chronic and acute pain syndromes in patients with multiple sclerosis. Acta Neurol 1994, 16:97–102.

    CAS  Google Scholar 

  26. Stenager E, Knudsen I, Jensen K: Acute and chronic pain syndromes in multiple sclerosis. Acta Neurol Scand 1991, 84:197–200.

    PubMed  CAS  Google Scholar 

  27. Moulin, Foley K, Ebers G: Pain syndromes in multiple sclerosis. Neurology 1988, 38:1830–1834.

    PubMed  CAS  Google Scholar 

  28. Ramirez-Lassepas M, Tulloch J, Quinones M, Snyder B: Acute radicular pain as a presenting symptom in multiple sclerosis. Arch Neurol 1992, 49:255–258.

    PubMed  CAS  Google Scholar 

  29. Samkoff LM, Daras M, Tuchman AJ, Koppel BS: Amelioration of refractory dysesthetic limb pain in multiple sclerosis by gabapentin. Neurology 1997, 49:304–305.

    PubMed  CAS  Google Scholar 

  30. Koutchens MK, Richert JR, Sami A: Open label gabapentin treatment for pain in multiple sclerosis. Mult Scler 1997, 3:250–253.

    Article  Google Scholar 

  31. Lunaardi G, Leandri M, Albano C, et al.: Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia. Neurology 1997, 48:1714–1717.

    Google Scholar 

  32. Jensen TS, Rasmussen P, Reske-Nielsene: Association of trigeminal neuralgia with multiple sclerosis: clinical and pathological features. Acta Neurol Scand 1982, 65:182–189.

    Article  PubMed  CAS  Google Scholar 

  33. Paty DW, Poser C: Clinical symptoms and signs of multiple sclerosis. In The Diagnosis of Multiple Sclerosis. Edited by Poser C. New York: Stuttgart:Thieme-Stratton; 1984:27–34.

    Google Scholar 

  34. Reder A, Arnason B: Trigeminal neuralgia in multiple sclerosis relieved by a prostaglandin E analogue. Neurology 1995, 45:1097–1100.

    PubMed  CAS  Google Scholar 

  35. Espir M, Millac P: Treatment of paroxysmal disorders in multiple sclerosis with carbamazepine (Tegretol). J Neurol Neurosurg Psychiatry 1970, 33:528–531.

    Article  PubMed  CAS  Google Scholar 

  36. Khan OA: Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients. Neurology 1998, 51:611–614.

    PubMed  CAS  Google Scholar 

  37. Golfino JG, Shetter AG: Treatment of trigeminal neuralgia in multiple sclerosis patients using radiofrequency thermal rhizotomy and glycerol rhizotomy. J Neurosurg 1993, 78:367.

    Google Scholar 

  38. Broggi G, Ferroli P, Franzini A, et al.: Microvascular decom pression for trigeminal neuralgia: comments on a series of 250 cases, including 10 patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 2000, 68:59–64.

    Article  PubMed  CAS  Google Scholar 

  39. Kondziolka D, Perez B, Flickinger JC, et al.: Gamma Knife radiosurgery for trigeminal neuralgia: results and expectations. Arch Neurol 1998, 55:1524–1529.

    Article  PubMed  CAS  Google Scholar 

  40. Urgosik D, Vymazal J, Vladyka V, Liscak R: Gamma knife treatment of trigeminal neuralgia: clinical and electrophysiological study. Sterotact Funct Neurosurg 1998, 70(suppl 1):200–209.

    Google Scholar 

  41. Brodeur C, Montplaisir J, Godbout R, Marinier R: Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: a double-blind, controlled study. Neurology 1988, 38:1845–1848.

    PubMed  CAS  Google Scholar 

  42. deMello MT, Poyares DL, Tufik S: Treatment of periodic leg movements with a dopaminergic agonist in subjects with total spinal cord lesions. Spinal Cord 1999, 37:634–637.

    Article  CAS  Google Scholar 

  43. Evidente VG, Adler CH, Caviness JN, et al.: Amantidine is beneficial in restless legs syndrome. Mov Disord 2000, 15:324–327.

    Article  PubMed  CAS  Google Scholar 

  44. Gehezzi A, Montanini R, Basso PF, et al.: Epilepsy in multiple sclerosis. Eur Neurol 1990, 30:218–223.

    Google Scholar 

  45. Sakurai M, Kanazawa I: Positive symptoms in multiple sclerosis: their treatment with sodium channel blockers, lidocaine and mexiletine. J Neurol Sci 1999, 162:162–168.

    Article  PubMed  CAS  Google Scholar 

  46. Tranchant C, Bhatia K, Marsden C: Movement disorders in multiple sclerosis. Mov Disord 1995, 10:418–423.

    Article  PubMed  CAS  Google Scholar 

  47. Posterb T, McMonagle U, Buttner, et al.: Paroxysmal convergence spasm in multiple sclerosis. Acta Neurol Scand 1996, 94:35–37.

    Google Scholar 

  48. Ezra E: Paroxysomal superior rectus and levator palpebrae spasm: a unique presentation of multiple sclerosis. Br J Ophthalmol 1996, 80:187–188.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Fairview Multiple Sclerosis Center and University of Minnesota, 701 25th Ave. South, #200, 55454, Minneapolis, MN, USA

    Randall T. Schapiro MD

Authors
  1. Randall T. Schapiro MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schapiro, R.T. Management of spasticity, pain, and paroxysmal phenomena in multiple sclerosis. Curr Neurol Neurosci Rep 1, 299–302 (2001). https://doi.org/10.1007/s11910-001-0034-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-001-0034-6

Keywords

Search

Navigation